| RS376461756 |
IMPG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS376462722 |
ABCA1
|
Health Risk |
Pathogenic |
— |
| RS376462752 |
KRT5
|
Health Risk |
Pathogenic |
Epidermolysis bullosa simplex, Epidermolysis bullosa simplex |
| RS376463335 |
RBM20
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary familial hypertrophic cardiomyopathy, Dilated cardiomyopathy 1DD |
| RS376463379 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 4, autosomal dominant |
| RS376464023 |
AHCY
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase, Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase |
| RS376465623 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS376465837 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group O |
| RS376466129 |
CNTNAP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cortical dysplasia-focal epilepsy syndrome, Cortical dysplasia-focal epilepsy syndrome |
| RS376468970 |
LRSAM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2P, Inborn genetic diseases |
| RS376469502 |
MYO15A
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Monogenic hearing loss |
| RS376469897 |
KIT
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Hereditary cancer-predisposing syndrome |
| RS376470294 |
MYO15A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS376470327 |
NALCN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS376470998 |
DNAH11
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS376471111 |
KIF1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease type 2 |
| RS376472014 |
FLNC
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Distal myopathy with posterior leg and anterior hand involvement |
| RS376472029 |
ABCD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Adrenoleukodystrophy, Inborn genetic diseases |
| RS376472075 |
RAD51D
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS376472382 |
TNXB
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS376474086 |
TMEM38B
|
Health Risk |
Pathogenic |
— |
| RS376475182 |
OBSL1
|
Health Risk |
Conflicting classifications of pathogenicity |
3M syndrome 2, 3M syndrome 2 |
| RS376475480 |
DNAH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 7 |
| RS376476266 |
NUP133
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephrotic syndrome, type 18 |
| RS376476299 |
NPRL3
|
Health Risk |
Conflicting classifications of pathogenicity |
Epilepsy, familial focal |
| RS376477553 |
GLI3
|
Health Risk |
Conflicting classifications of pathogenicity |
Pallister-Hall syndrome, Greig cephalopolysyndactyly syndrome |
| RS376478015 |
AP4B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 47, Spastic paraplegia |
| RS376478331 |
COQ8A
|
Health Risk |
Pathogenic |
— |
| RS376478363 |
CLN3
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronal ceroid lipofuscinosis 3, Neuronal ceroid lipofuscinosis |
| RS376478864 |
COL5A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, classic type |
| RS376480977 |
PAH
|
Health Risk |
Likely pathogenic |
Phenylketonuria, Hepatocellular carcinoma |
| RS376482004 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Malignant hyperthermia |
| RS376483324 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome, KMT2D-related disorder |
| RS376483549 |
PLEC
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2Q, Epidermolysis bullosa simplex with nail dystrophy |
| RS376484117 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS376484231 |
CYFIP2
|
Health Risk |
Conflicting classifications of pathogenicity |
See cases, Inborn genetic diseases |
| RS376486225 |
AGL
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS3764873 |
SCNN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Bronchiectasis with or without elevated sweat chloride 2, Pseudohypoaldosteronism |
| RS376487338 |
DRAM2
|
Health Risk |
Pathogenic |
— |
| RS376487384 |
MYLK3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS376487588 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group J, Familial cancer of breast |
| RS376487875 |
FRAS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fraser syndrome 1, FRAS1-related disorder |
| RS376488313 |
FANCD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group D2, Fanconi anemia |
| RS376488491 |
GSN
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS376488796 |
COL4A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS376489465 |
ABRAXAS1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS376491126 |
DST
|
Health Risk |
Pathogenic |
Epidermolysis bullosa simplex 3, localized or generalized intermediate |
| RS376491227 |
SAMD9L
|
Health Risk |
Conflicting classifications of pathogenicity |
Monosomy 7 myelodysplasia and leukemia syndrome 1, Ataxia-pancytopenia syndrome |
| RS376491803 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 4, autosomal dominant |
| RS376492641 |
NPHP1
|
Health Risk |
Pathogenic |
Nephronophthisis, Joubert syndrome with renal defect |
| RS376492799 |
DYNC1H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2O, Charcot-Marie-Tooth disease axonal type 2O |
| RS376493409 |
CEP290
|
Health Risk |
Pathogenic |
Joubert syndrome 5, Global developmental delay |
| RS376494248 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS376494747 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS376494828 |
PLEC
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa simplex 5C, with pyloric atresia |
| RS376495046 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Inborn genetic diseases |
| RS376495346 |
ARID1B
|
Health Risk |
Pathogenic |
— |
| RS376496085 |
CBS
|
Health Risk |
Conflicting classifications of pathogenicity |
HYPERHOMOCYSTEINEMIA, THROMBOTIC |
| RS376496267 |
ELN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cutis laxa, autosomal dominant 1 |
| RS376496894 |
RSPH9
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS3764971 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS376497158 |
CDH23
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 1D, Autosomal recessive nonsyndromic hearing loss 12 |
| RS376497190 |
BBS10
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 10 |
| RS376497490 |
INSR
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS376497842 |
ARID1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS376498106 |
VPS13B
|
Health Risk |
Conflicting classifications of pathogenicity |
Cohen syndrome, Inborn genetic diseases |
| RS376498798 |
CHD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy 94, Inborn genetic diseases |
| RS376498905 |
EPG5
|
Health Risk |
Conflicting classifications of pathogenicity |
Vici syndrome, Inborn genetic diseases |
| RS376499470 |
PRKAG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Lethal congenital glycogen storage disease of heart, Cardiomyopathy |
| RS376500523 |
OBSCN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS376500610 |
RPGRIP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Leber congenital amaurosis 1, Leber congenital amaurosis 6 |
| RS376501876 |
GUSB
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis type 7, Inborn genetic diseases |
| RS376502356 |
FH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary leiomyomatosis and renal cell cancer |
| RS376502783 |
COL7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, COL7A1-related disorder |
| RS376503299 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Inborn genetic diseases |
| RS376503331 |
NOTCH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hajdu-Cheney syndrome, NOTCH2-related disorder |
| RS376504548 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary familial hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS376505218 |
KCNC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive myoclonic epilepsy type 7, Progressive myoclonic epilepsy type 7 |
| RS376505416 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 2C, Inborn genetic diseases |
| RS376505442 |
SCN4A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperkalemic periodic paralysis, 7 conditions |
| RS376505707 |
GUSB
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis type 7, Inborn genetic diseases |
| RS376505803 |
CD19
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency, common variable |
| RS376506263 |
GJB3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS376507178 |
FBN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital contractural arachnodactyly, Congenital heart disease |
| RS376507352 |
SYNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 5, autosomal dominant |
| RS376509451 |
DOK7
|
Health Risk |
Conflicting classifications of pathogenicity |
Fetal akinesia deformation sequence 1, Congenital myasthenic syndrome 10 |
| RS376509886 |
NDUFS6
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex I deficiency, nuclear type 1 |
| RS376510148 |
FUS
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis type 6, Tremor |
| RS376510159 |
SRCAP
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental delay, hypotonia |
| RS376510352 |
DNAH5
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 3 |
| RS376510526 |
ABCA13
|
Health Risk |
Conflicting classifications of pathogenicity |
Thyroid cancer, nonmedullary |
| RS376510669 |
VCP
|
Health Risk |
Conflicting classifications of pathogenicity |
Frontotemporal dementia and/or amyotrophic lateral sclerosis 6, Inclusion body myopathy with Paget disease of bone and frontotemporal dementia |
| RS376511120 |
FLNB
|
Health Risk |
Conflicting classifications of pathogenicity |
FLNB-Related Spectrum Disorders, FLNB-related disorder |
| RS376511134 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, NEB-related disorder |
| RS376511242 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia, Beauce type |
| RS376512300 |
TECPR1
|
Health Risk |
Likely pathogenic |
Moyamoya angiopathy, Moyamoya angiopathy |
| RS376512605 |
LAMC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Junctional epidermolysis bullosa, Junctional epidermolysis bullosa |
| RS376513000 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Brittle cornea syndrome 1 |
| RS376513788 |
CCDC78
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myopathy with internal nuclei and atypical cores, Inborn genetic diseases |
| RS376514006 |
COL12A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ullrich congenital muscular dystrophy 2, Bethlem myopathy 2 |